Owen Hughes is the founder of Cullinan Oncology. Cullinan Oncology has raised $499M in total funding. Latest round: IPO. Based in Cambridge, Massachusetts.
Owen Hughes is the former CEO and co-founder of Cullinan Oncology, a biopharmaceutical company focused on developing targeted cancer therapies. He led the company through its initial $150 million Series A financing in 2017, a $98.5 million Series B in 2020, and a $250 million IPO in 2021. Hughes subsequently served as CEO of Sail Bio and later became the full-time CEO of XOMA in January 2024.
Full founder directory · Investor directory · Company funding database · Fundraising library